vs
ICU MEDICAL INC（ICUI）与Mativ Holdings, Inc.（MATV）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Mativ Holdings, Inc.的1.2倍（$540.7M vs $463.1M），Mativ Holdings, Inc.净利率更高（21.8% vs -2.9%，领先24.7%），Mativ Holdings, Inc.同比增速更快（1.0% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $8.0M），过去两年ICU MEDICAL INC的营收复合增速更高（-2.3% vs -3.8%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Mativ Holdings是一家全球特种材料制造商，主要生产高性能先进聚合物、无纺布、过滤解决方案及功能性涂层材料，服务医疗、工业、消费品、航空航天、能源等领域，业务遍及北美、欧洲及亚太地区。
ICUI vs MATV — 直观对比
营收规模更大
ICUI
是对方的1.2倍
$463.1M
营收增速更快
MATV
高出15.1%
-14.1%
净利率更高
MATV
高出24.7%
-2.9%
自由现金流更多
ICUI
多$28.0M
$8.0M
两年增速更快
ICUI
近两年复合增速
-3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $463.1M |
| 净利润 | $-15.7M | $100.8M |
| 毛利率 | 37.5% | 18.8% |
| 营业利润率 | 1.0% | 2.2% |
| 净利率 | -2.9% | 21.8% |
| 营收同比 | -14.1% | 1.0% |
| 净利润同比 | 34.0% | 6620.0% |
| 每股收益（稀释后） | $-0.63 | $1.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUIMATV
| Q4 25 | $540.7M | $463.1M | ||
| Q3 25 | $537.0M | $513.7M | ||
| Q2 25 | $548.9M | $525.4M | ||
| Q1 25 | $604.7M | $484.8M | ||
| Q4 24 | $629.8M | $458.6M | ||
| Q3 24 | $589.1M | $498.5M | ||
| Q2 24 | $596.5M | $523.8M | ||
| Q1 24 | $566.7M | $500.2M |
净利润ICUIMATV
| Q4 25 | $-15.7M | $100.8M | ||
| Q3 25 | $-3.4M | $-3.2M | ||
| Q2 25 | $35.3M | $-9.5M | ||
| Q1 25 | $-15.5M | $-425.5M | ||
| Q4 24 | $-23.8M | $1.5M | ||
| Q3 24 | $-33.0M | $-20.8M | ||
| Q2 24 | $-21.4M | $-1.4M | ||
| Q1 24 | $-39.5M | $-28.0M |
毛利率ICUIMATV
| Q4 25 | 37.5% | 18.8% | ||
| Q3 25 | 37.4% | 19.3% | ||
| Q2 25 | 37.9% | 19.7% | ||
| Q1 25 | 34.7% | 15.0% | ||
| Q4 24 | 36.1% | 16.9% | ||
| Q3 24 | 34.8% | 18.8% | ||
| Q2 24 | 34.8% | 20.8% | ||
| Q1 24 | 32.7% | 16.8% |
营业利润率ICUIMATV
| Q4 25 | 1.0% | 2.2% | ||
| Q3 25 | 2.6% | 3.1% | ||
| Q2 25 | 1.9% | 3.8% | ||
| Q1 25 | 2.1% | -88.8% | ||
| Q4 24 | 6.0% | 0.6% | ||
| Q3 24 | 1.4% | 1.4% | ||
| Q2 24 | 1.3% | 2.0% | ||
| Q1 24 | -1.9% | -2.8% |
净利率ICUIMATV
| Q4 25 | -2.9% | 21.8% | ||
| Q3 25 | -0.6% | -0.6% | ||
| Q2 25 | 6.4% | -1.8% | ||
| Q1 25 | -2.6% | -87.8% | ||
| Q4 24 | -3.8% | 0.3% | ||
| Q3 24 | -5.6% | -4.2% | ||
| Q2 24 | -3.6% | -0.3% | ||
| Q1 24 | -7.0% | -5.6% |
每股收益（稀释后）ICUIMATV
| Q4 25 | $-0.63 | $1.87 | ||
| Q3 25 | $-0.14 | $-0.06 | ||
| Q2 25 | $1.43 | $-0.18 | ||
| Q1 25 | $-0.63 | $-7.82 | ||
| Q4 24 | $-0.97 | $0.03 | ||
| Q3 24 | $-1.35 | $-0.38 | ||
| Q2 24 | $-0.88 | $-0.03 | ||
| Q1 24 | $-1.63 | $-0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $84.2M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $2.1B | $498.7M |
| 总资产 | $4.1B | $2.1B |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势，按日历期对齐
现金及短期投资ICUIMATV
| Q4 25 | — | $84.2M | ||
| Q3 25 | — | $97.1M | ||
| Q2 25 | — | $95.6M | ||
| Q1 25 | — | $84.0M | ||
| Q4 24 | $308.6M | $94.3M | ||
| Q3 24 | $312.5M | $162.2M | ||
| Q2 24 | $302.6M | $133.4M | ||
| Q1 24 | $251.4M | $128.9M |
总债务ICUIMATV
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
股东权益ICUIMATV
| Q4 25 | $2.1B | $498.7M | ||
| Q3 25 | $2.1B | $397.4M | ||
| Q2 25 | $2.1B | $416.6M | ||
| Q1 25 | $2.0B | $428.2M | ||
| Q4 24 | $2.0B | $858.5M | ||
| Q3 24 | $2.0B | $882.3M | ||
| Q2 24 | $2.0B | $898.0M | ||
| Q1 24 | $2.1B | $906.9M |
总资产ICUIMATV
| Q4 25 | $4.1B | $2.1B | ||
| Q3 25 | $4.1B | $2.0B | ||
| Q2 25 | $4.1B | $2.1B | ||
| Q1 25 | $4.2B | $2.1B | ||
| Q4 24 | $4.2B | $2.4B | ||
| Q3 24 | $4.3B | $2.6B | ||
| Q2 24 | $4.3B | $2.6B | ||
| Q1 24 | $4.3B | $2.7B |
负债/权益比ICUIMATV
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 2.63× | ||
| Q2 25 | — | 2.66× | ||
| Q1 25 | — | 2.67× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | — | 1.29× | ||
| Q1 24 | — | 1.30× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $8.0M |
| 自由现金流率自由现金流/营收 | 6.6% | 1.7% |
| 资本支出强度资本支出/营收 | 4.6% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.19× |
| 过去12个月自由现金流最近4个季度 | $91.8M | $93.8M |
8季度趋势，按日历期对齐
经营现金流ICUIMATV
| Q4 25 | $60.6M | $19.3M | ||
| Q3 25 | $56.7M | $72.8M | ||
| Q2 25 | $11.2M | $57.6M | ||
| Q1 25 | $51.3M | $-15.9M | ||
| Q4 24 | $40.2M | $24.1M | ||
| Q3 24 | $36.1M | $37.6M | ||
| Q2 24 | $82.0M | $46.1M | ||
| Q1 24 | $45.8M | $-13.0M |
自由现金流ICUIMATV
| Q4 25 | $36.0M | $8.0M | ||
| Q3 25 | $27.6M | $66.7M | ||
| Q2 25 | $-8.5M | $48.9M | ||
| Q1 25 | $36.7M | $-29.8M | ||
| Q4 24 | $16.1M | $2.0M | ||
| Q3 24 | $16.2M | $25.5M | ||
| Q2 24 | $62.5M | $37.4M | ||
| Q1 24 | $29.9M | $-25.1M |
自由现金流率ICUIMATV
| Q4 25 | 6.6% | 1.7% | ||
| Q3 25 | 5.1% | 13.0% | ||
| Q2 25 | -1.5% | 9.3% | ||
| Q1 25 | 6.1% | -6.1% | ||
| Q4 24 | 2.6% | 0.4% | ||
| Q3 24 | 2.7% | 5.1% | ||
| Q2 24 | 10.5% | 7.1% | ||
| Q1 24 | 5.3% | -5.0% |
资本支出强度ICUIMATV
| Q4 25 | 4.6% | 2.4% | ||
| Q3 25 | 5.4% | 1.2% | ||
| Q2 25 | 3.6% | 1.7% | ||
| Q1 25 | 2.4% | 2.9% | ||
| Q4 24 | 3.8% | 4.8% | ||
| Q3 24 | 3.4% | 2.4% | ||
| Q2 24 | 3.3% | 1.7% | ||
| Q1 24 | 2.8% | 2.4% |
现金转化率ICUIMATV
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 16.07× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
MATV
| Other | $208.7M | 45% |
| SAS Segment | $157.4M | 34% |
| FAM Segment | $97.0M | 21% |
